| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $49,058,932 ) (Continued on the next page) |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK107680 | Ketones, Muscle Metabolism, and SGLT2 Inhibitors | 001 | 9 | NIH | 4/30/2025 | $0 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK107680 | Ketones, Muscle Metabolism, and SGLT2 Inhibitors | 000 | 9 | NIH | 4/2/2025 | $582,600 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH099660 | Postnatal mechanisms of cognitive development in mice | 000 | 13 | NIH | 4/4/2025 | $494,992 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086496 | The Hippo signaling pathway as a target of intervention for Alzheimer’s disease | 000 | 2 | NIH | 3/21/2025 | $485,560 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293655 | Structure and function of RAD51 paralog tumor suppressor complexes in genome maintenance | 000 | 2 | NIH | 4/21/2025 | $576,368 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 001 | 4 | NIH | 5/5/2025 | $72,458 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 000 | 4 | NIH | 1/6/2025 | $652,130 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25NS115552 | Summer Physiology Undergraduate Researcher (SPUR) Program | 000 | 5 | NIH | 11/29/2024 | $107,680 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK138035 | Paracrine effects of leptin in regulating visceral fat expansion | 000 | 2 | NIH | 2/27/2025 | $348,750 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153425 | Defining conserved epitopes on polymorphic malaria antigens | 000 | 5 | NIH | 1/23/2025 | $527,357 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI186304 | Translational Control of Conidial Germination in Aspergillus fumigatus | 000 | 2 | NIH | 4/7/2025 | $232,500 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES007061 | Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice | 001 | 31 | NIH | 12/16/2024 | $51,484 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES007061 | Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice | 000 | 31 | NIH | 12/13/2024 | $505,540 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01EY012085 | Intercellular Communication in the Eye Lens | 000 | 27 | NIH | 12/20/2024 | $419,959 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS128574 | Chronic Intermittent Hypoxia and Hyperalgesic Priming | 000 | 3 | NIH | 2/13/2025 | $560,256 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133304 | A novel pathway controls liver injury in NASH | 000 | 4 | NIH | 4/16/2025 | $519,180 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31NS131025 | Establishing an Atrophy-Based Functional Network Model as a Biomarker for Seizure-Onset Laterality | 000 | 2 | NIH | 11/29/2024 | $38,476 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279696 | The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer | 000 | 3 | NIH | 3/31/2025 | $337,870 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD108124 | The genome integrity and epigenome of sperm from men with recurrent pregnancy loss | 001 | 3 | NIH | 4/3/2025 | $64,210 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD108124 | The genome integrity and epigenome of sperm from men with recurrent pregnancy loss | 000 | 3 | NIH | 4/2/2025 | $577,884 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM147636 | The role of EWSR1 at the centromere | 000 | 3 | NIH | 3/28/2025 | $310,000 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269766 | Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments | 000 | 3 | NIH | 5/13/2025 | $575,193 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 000 | 1 | NIH | 1/29/2025 | $487,386 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA277682 | Drug Development of Skp2 PROTACs in Cancer | 002 | 4 | NIH | 4/10/2025 | $578,928 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 000 | 5 | NIH | 1/28/2025 | $452,461 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25DE032518 | Dental Research Intensive Program for Undergradate Students | 000 | 1 | NIH | 1/28/2025 | $134,934 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 000 | 4 | NIH | 4/22/2025 | $556,642 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AR077445 | Repurposing esomeprazole for the treatment of scleroderma | 002 | 4 | NIH | 4/29/2025 | $511,584 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 001 | 3 | NIH | 4/8/2025 | $42,556 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 000 | 3 | NIH | 1/27/2025 | $383,014 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R18HS027756 | Dissemination and implementation of a telehealth program to deliver effective antibiotic stewardship support to rural or medically underserved newborn nurseries. | 000 | 4 | AHRQ | 2/7/2025 | $171,225 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK129676 | Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers | 000 | 4 | NIH | 4/18/2025 | $682,154 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 000 | 6 | NIH | 2/13/2025 | $297,176 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA249305 | The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC | 000 | 6 | NIH | 2/13/2025 | $338,343 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG061729 | Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimer’s disease | 000 | 3 | NIH | 3/4/2025 | $571,995 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 000 | 12 | NIH | 2/24/2025 | $616,424 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293672 | Developing purinergic receptor inverse agonists for treating triple negative breast cancer | 000 | 1 | NIH | 2/24/2025 | $616,071 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00AG068239 | Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan | 000 | 5 | NIH | 3/7/2025 | $224,100 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 001 | 1 | NIH | 3/12/2025 | $0 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 000 | 1 | NIH | 3/12/2025 | $41,506 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 4 | NIH | 2/13/2025 | $473,813 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 000 | 8 | NIH | 3/3/2025 | $287,372 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 000 | 3 | NIH | 3/20/2025 | $3,246,532 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH125979 | Gene editing in the brain with CRISPR-PEG | 000 | 5 | NIH | 2/13/2025 | $567,518 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 3 | NIH | 3/3/2025 | $475,723 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA237159 | Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue | 000 | 6 | NIH | 3/5/2025 | $182,140 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH127216 | Neural connectivity before and after each of the three treatment phases of trauma-focused therapy for adolescent posttraumatic stress | 000 | 4 | NIH | 3/5/2025 | $658,794 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA289167 | Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression | 000 | 2 | NIH | 3/3/2025 | $160,937 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA286307 | Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage | 000 | 2 | NIH | 11/1/2024 | $194,387 |
|
